Pharmaceutical Technology, October 2022

External expertise is beneficial in helping companies select the right tools at the right stages of development to ensure success.

This article introduces a control chart technique using F statistic for continued process verification of oral solid dosage forms.

There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.

Standardized risk assessment and analysis protocols facilitate the comparison of processing equipment components.

BFS technology can help maintain sterility during the biologics manufacturing process.

Numerous benefits will eventually lead to large-scale applications in pharmaceutical manufacturing.

Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.

Some of the greatest advancements in drug delivery are related to disposable delivery devices, vaccine adjuvants, and wearable pumps, according to Nicholas W. Warne of Pfizer.

Various advances in contamination control are being utilized to reduce the chance pollutants contaminate a drug product.

Awareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements.

Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.

A blended approach to newly revised regulatory guidance to inform environmental monitoring programmes is essential.

Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.

Pharmaceutical Technology Europe pays tribute to the role Her Majesty Queen Elizabeth II had in promoting innovation within life sciences.

Under the revised NIS-2 Directive in Europe, pharma companies will need to be proactive in safeguarding their digital assets.

FDA backs joint reviews, common research policies, and modern production methods around the world.

One can only learn the secrets of "fight club" by attending its meetings.

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, addresses the difference between regulatory compliance and real compliance.

ROSS Ribbon Blenders are a customizable solution designed to minimize risk and maximize productivity.

The new inorganic pyrophosphate from Canvax is intended for use in RNA IVT reactions.

L.B. Bohle’s QbCon 1 is intended to meet all quality requirements for long granulation processing time.

Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.

The 1VQ papers advocate for the idea that certain post-approval changes should be streamlined and expedited.